Trial intelligence / Profile preview

Kids-DOTT pediatric thrombosis duration trial

NL-OMON46920Phase 3Withdrawn

Sponsor
Johns Hopkins All Children's Hospital
Start
May 2018
Countries
1
01

Overview

Phase 3, randomised, open-label trial in venous thromboembolism (VTE), Phlebothrombosis and pulmonary embolism (PE), sponsored by Johns Hopkins All Children's Hospital. Planned start May 2018; status: withdrawn.

02

Conditions

venous thromboembolism (VTE)Phlebothrombosispulmonary embolism (PE)

Beyond the preview

Go deeper on NL-OMON46920.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON46920.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call